These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1425537)

  • 41. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial.
    Ashraf H; Mahalanabis D; Mitra AK; Tzipori S; Fuchs GJ
    Acta Paediatr; 2001 Dec; 90(12):1373-8. PubMed ID: 11853331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imperatorin a furocoumarin inhibits periplasmic Cu-Zn SOD of Shigella dysenteriae their by modulates its resistance towards phagocytosis during host pathogen interaction.
    Raja SB; Murali MR; Roopa K; Devaraj SN
    Biomed Pharmacother; 2011 Dec; 65(8):560-8. PubMed ID: 21194882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [An analysis of meat products as possible factors responsible for transmission of dysenterial toxic infections].
    Sedova NN
    Vopr Pitan; 1975; (5):68-73. PubMed ID: 1108439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized trial of high- and low-dose ampicillin therapy for treatment of severe dysentery due to Shigella dysenteriae type 1.
    Gilman RH; Koster F; Islam S; McLaughlin J; Rahaman MM
    Antimicrob Agents Chemother; 1980 Mar; 17(3):402-5. PubMed ID: 6999981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental shigellosis in mice. II. Immunological responses to Shigella dysenteriae type 2 infection.
    COOPER GN; PILLOW JA
    Aust J Exp Biol Med Sci; 1959 Jun; 37():201-9. PubMed ID: 13811789
    [No Abstract]   [Full Text] [Related]  

  • 46. Rare type of shigellosis.
    J Iowa Med Soc; 1976 Feb; 66(2):44-5. PubMed ID: 765409
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular Mechanisms of
    Pakbin B; Brück WM; Brück TB
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768771
    [No Abstract]   [Full Text] [Related]  

  • 48. Experimental shigellosis in mice. I. Chronic infection with Shigella dysenteriae type 2.
    COOPER GN
    Aust J Exp Biol Med Sci; 1959 Jun; 37():193-200. PubMed ID: 13811790
    [No Abstract]   [Full Text] [Related]  

  • 49. Experimental shigellosis and intestinal malabsorption in the mouse.
    Madge DS
    Comp Biochem Physiol A Comp Physiol; 1974 Jun; 48(2):343-59. PubMed ID: 4151366
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial.
    Bennish ML; Salam MA; Khan WA; Khan AM
    Ann Intern Med; 1992 Nov; 117(9):727-34. PubMed ID: 1416574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral blood neutrophil responses in children with shigellosis.
    Azim T; Islam LN; Halder RC; Hamadani J; Khanum N; Sarker MS; Salam MA; Albert MJ
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):616-22. PubMed ID: 8548543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokines in the stools of children with complicated shigellosis.
    Azim T; Halder RC; Sarker MS; Ahmed S; Hamadani J; Chowdhury A; Qadri F; Salam MA; Sack RB; Albert MJ
    Clin Diagn Lab Immunol; 1995 Jul; 2(4):492-5. PubMed ID: 7583932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of mongoloids to infection; incidence of pneumonia, influenza A and Shigella dysenteriae, Sonne.
    SIEGEL M
    Am J Hyg; 1948 Jul; 48(1):53-62. PubMed ID: 18872694
    [No Abstract]   [Full Text] [Related]  

  • 54. Shigella dysenteriae type 1 enterocolitis.
    Caldwell GR; Reiss-Levy EA; de Carle DJ; Hunt DR
    Aust N Z J Med; 1986 Jun; 16(3):405-7. PubMed ID: 3535768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Chestnut (
    Peng F; Chen L; Wang X; Yu Z; Cheng C; Yang Y
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836834
    [No Abstract]   [Full Text] [Related]  

  • 56. [Studies on stain agglutination and electrophretic behavior of dysentery bacteria. I. Shigella dysenteriae].
    WAGNER WH; BREDEHORST H
    Zentralbl Bakteriol Orig; 1953 Apr; 159(5):323-30. PubMed ID: 13091063
    [No Abstract]   [Full Text] [Related]  

  • 57. The leukemoid reaction in shigellosis.
    Butler T; Islam MR; Bardhan PK
    Am J Dis Child; 1984 Feb; 138(2):162-5. PubMed ID: 6695872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study on toxins and antigens of Shigella dysenteriae; toxicity and antigenicity of whole organisms and various fractions of Shigella dysenteriae.
    BOROFF DA
    J Bacteriol; 1949 Jun; 57(6):617-32. PubMed ID: 18150948
    [No Abstract]   [Full Text] [Related]  

  • 59. Release of interleukin-2 induced by a major antigenic outer membrane protein of Shigella dysenteriae type 1 in natural infection.
    Chakrabarti S; Sinha AK
    Microbios; 1997; 92(371):123-32. PubMed ID: 9589610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lactobacilli inhibit Shigella dysenteriae 1 induced pro-inflammatory response and cytotoxicity in host cells via impediment of Shigella-host interactions.
    Moorthy G; Murali MR; Niranjali Devaraj S
    Dig Liver Dis; 2010 Jan; 42(1):33-9. PubMed ID: 19535308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.